[EN] 4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV INHIBITORS<br/>[FR] DÉRIVÉS DE 4,4'-BIPHÉNYLDIYL BIS-(1H-IMIDAZOLYLE) COMME INHIBITEURS DU VHC
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2015088817A1
公开(公告)日:2015-06-18
The present disclosure relates to compounds of formula (I), pharmaceutical compositions and and use thereof in treatment of hepatitis C virus (HCV) infection.
本公开涉及式(I)的化合物,制药组合物以及其在治疗丙型肝炎病毒(HCV)感染中的应用。